Project Grant R21DE031906

Award Date 8/1/23
Completion Date 7/31/25
Dollars Obligated $432K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under its Oral Diseases and Disorders Research program (CFDA 93.121) provides $434,746 to Nova Southeastern University, Inc. to investigate the impact of diabetes-induced hyperglycemia on the development of peri-implantitis, a common complication following dental implant placement. The project aims to elucidate the mechanisms by which hyperglycemia leads to changes in the oral microbiome and promotes...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $873,546 Project Grant under the Oral Diseases and Disorders Research Program (CFDA 93.121) to the University of Texas Health Science Center at Houston (UTHealth). The grant aims to develop a biomaterial-enhanced system for targeted localization of engineered probiotic bacteria (Limosilactobacillus reuteri) that secrete the anti-inflammatory cytokine interleukin-10 (IL-10) to treat experimental periodontitis. The key...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $148,568 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the Regents of the University of Michigan. The 18-month project aims to develop innovative biomarkers and a machine learning classifier to improve the characterization and monitoring of periodontal inflammation using quantitative ultrasound and image texture analysis techniques. Specifically, the research will investigate...
This Project Grant award, totaling $446,875.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The award supports research to investigate the role of a novel G protein-coupled receptor (MRGPRX2/MRGPRB2) expressed on mast cells and its contribution to the development of periodontal disease. The research aims to develop humanized mouse models to study the impact of this receptor and its...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), totaling $557,606.00, supports research aimed at advancing the understanding of periodontal stem cells and their regulation for more predictable and efficient periodontal tissue regeneration. The key research objectives are to: 1) characterize the properties of periodontal crestal stem cells (PCSCs) and their activation by...
This federal Project Grant award, valued at $185,918.00 and issued by the National Institute of Dental and Craniofacial Research (NIDCR), supports research under the Oral Diseases and Disorders Research program (CFDA 93.121). The project aims to evaluate the impact of Medicaid coverage for treatment of periodontal disease on oral health outcomes and control of chronic diseases like diabetes among Medicaid beneficiaries. The research will leverage Medicaid claims data from 2016-2023 to assess the...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $236,250 to investigate the relationship between adverse childhood experiences (ACEs), oral microbiome dysbiosis, and dental caries in children. The research aims to identify potential causative mechanisms between ACEs, the brain-oral microbiome axis, and increased risk of dental caries in children, with the...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), provides $858,000 in funding to the University of Texas Health Science Center at Houston (UTHealth) from September 2024 to September 2026. The research project aims to investigate the mechanisms by which the anaerobic bacterium Veillonella inhibits the hemolytic activity of the periodontal pathogen Porphyromonas...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) totals $588,952 and will run from April 2025 to March 2030. The funding will support the development and optimization of a bio-inspired tubular matrix scaffold to guide the formation of periodontal ligament (PDL) principal fibers and rebuild the microenvironment for the regeneration of Sharpey's fibers, which are critical for...
This $241,500 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121) will fund research to identify diffusible small molecules that regulate the replication of the oral bacterium Porphyromonas gingivalis (P. gingivalis). The research aims to establish the identity of growth-promoting cues produced by different strains of P. gingivalis and the early biofilm colonizer Veillonella...

The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $432,209 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to the University of California, Los Angeles (UCLA) for a 2-year period starting on August 1, 2023. The funding supports research to investigate the role of the CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus on periodontitis. Specifically, the research aims to further elucidate the role of CXCL10 in the periodontium and determine if inhibition of the CXCR3 receptor can mitigate the detrimental effects of diabetes on periodontal destruction. This project builds on prior findings from the UCLA research team demonstrating the importance of the CXCL10-CXCR3 signaling pathway in the development of experimental periodontal disease. The research will be conducted at UCLA's facilities in California.

Generated 7/16/24, 7:01 AM